A Multicenter, Open-label Extension Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE-120101 in Patients with Huntington's Disease.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Burn, Katherine (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/20 → 30/04/23

Keywords

  • Neurological disorders
  • Huntington's disease
  • Clinical trial